Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEVRO PLC Earnings Release 2020

Jan 18, 2021

4717_er_2021-01-18_3a59ff8c-1e2b-4d79-abe8-bc1f1dfbaf9a.html

Earnings Release

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9290L

Devro PLC

18 January 2021

18 January 2021

Devro plc

Trading update

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the year ended 31 December 2020.

Trading in the final months of 2020 was slightly ahead of management's expectations, driven by higher volumes and margins. As such, the expected outturn for Group underlying operating profit, subject to audit, is around the upper end of current analyst expectations1.

The Group delivered strong cash generation in the final quarter. Net debt at the end of December 2020 was circa £110 million.

Devro will announce its results for the year ended 31 December 2020 on 2 March 2021.

Contacts:

Devro plc

Rutger Helbing Chief Executive Officer Tel: 020 3865 7637
Rohan Cummings Chief Financial Officer

FTI Consulting

Richard Mountain / Nick Hasell Tel: 020 3727 1340

1 Company compiled consensus 2020 operating profit range between £38.0 and £40.5 million

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTDELFFFFLEBBL